Page 5 - Granules India

Granules Q1 net profit up 36% at Rs 39 crore

Total income from operations grew 6.56% to Rs 343.73 crore in the quarter from Rs 322.56 crore in the year ago period

Granules acquires 12.5% stake in USpharma

The company did not disclose the details about exact payout being made towards this stake buy, citing confidentiality agreement

Granules India gains on product in-licensing pact with US firm

The company's US arm has exclusive agreement with USpharma Windlas, LLC for product in-licensing

Granules acquires exclusive product rights from US pharma company

Windlas through its subsidiaries holds Abbreviated New Drug Applications (ANDAs) for Fingolimod, Prasugrel, Dronedarone and Lurasidone

Granules India gets establishment inspection report from USFDA

For the inspection done at the company's Jeedimetla plant in Telangana